article thumbnail

Overactive Bladder Diagnoses Tripled, but Treatment Is Still Rare

Drugs.com

22, 2025 -- A sudden need to urinate is more common than previously known, but treatment is less common.Diagnoses for overactive bladder more than tripled between 2013 and 2017, after the American Urological Association (AUA). WEDNESDAY, Jan.

Treatment 255
article thumbnail

Behind the new kind of cell therapy that just won FDA approval

BioPharma Drive: Drug Pricing

One expert views Amtagvi’s approval as a catalyst for further investment in TIL therapies, akin to how Kymriah’s 2017 clearance buoyed CAR-T treatment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech leader champions targeted cancer treatments and diversity

Drug Target Review

As the CEO of iOnctura, an innovative oncology biopharmaceutical company she co-founded in 2017, Catherine has played a key role in advancing the development of highly targeted small molecules aimed at revolutionising cancer treatment. So, with a huge amount of courage and commitment, I co-founded iOnctura in 2017.

article thumbnail

Transforming cancer treatment for greatest impact

Drug Target Review

Could you provide insights into the driving factors behind exploring novel treatments for cancer types? Could you provide further details on how this phenomenon could impact broader treatment outcomes? What aspects prompted this research direction? The concept of the ‘abscopal effect’ in the 4T1 tumour model is intriguing.

Treatment 105
article thumbnail

Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Treatment

Common Sense for Drug Policy Blog

Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Treatment "The findings revealed that exposures to MOUD, even if not continued throughout the six-month exposure period was associated with reduced risk of a fatal poisoning compared to non-MOUD forms of treatment and no treatment exposure.

article thumbnail

A research team searches for every gene that helps tumors evade immunotherapy

Broad Institute

Manguso, who’d recently graduated from college and was conducting research at the University of Copenhagen as a Fulbright scholar, moved back to the Boston area to be with his mother as she underwent treatment. His mother had a presentation of the disease that suggested her immune system was already on the job.

Research 137
article thumbnail

Primary Aldosteronism Testing Rare in Treatment-Resistant HTN

The Pharma Data

Primary Aldosteronism Testing Rare in Treatment-Resistant HTN. 29, 2020 — Patients with apparent treatment-resistant hypertension are rarely tested for primary aldosteronism, according to a study published online Dec. Veterans Health Administration with apparent treatment-resistant hypertension from 2000 to 2017.